About Us

Developing high performance personalized diagnostics.

Our industry-leading team combines microbiology, biochemistry and molecular biology expertise with advanced product development know-how. We are developing genomic barcoding-based diagnostics to identify and track drug-resistant human pathogens.

Meet Our Board

Evgeni Sokurenko, M.D., Ph.D.


Dr. Evgeni Sokurenko is the Founder of ID Genomics, Inc. He has more than 25 years of experience conducting, generating funds for, and directing microbiology, biochemistry, and epidemiological research. He provides scientific leadership and manages ID Genomics’ scientific collaborations. Dr. Sokurenko is a professor of Microbiology at the University of Washington, where he has been a member of the faculty since 1999. He has published over 100 peer-reviewed papers in the area of bacterial pathogenesis and multi-drug resistance, and is a co-inventor of ID Genomics’ technology.

Frederick Huntsberry

Frederick is a highly experienced C-level executive & strategic thinker with significant experience in finance and operations, most notably serving the entertainment, manufacturing & service industries in NA, Europe & Asia. Prior positions include the COO of Paramount Pictures and President of NBC Universal Television Distribution.  Frederick currently serves as a Director on several Boards and brings his financial and operational wisdom to ID Genomics.

Mansour Samadpour, Ph.D.

Dr. Samadpour is the President of IEH Laboratories and Consulting Group (IEH), and Molecular Epidemiology, Inc. (MEI).  He holds B.S. and M.S. degrees in Microbiology and a Ph.D. degree in Food Science and Technology and Molecular Biology from the University of Washington.  After completing his Ph.D., Dr. Samadpour served as faculty at the University of Washington until 2003.  In 2001, he founded IEH and MEI, which now have 130 ISO certified laboratories nationwide and are the largest players in the food and water safety testing industry.

Meet Our Senior Executives

Linda Zuckerman, Ph.D.

President & C.E.O


 Linda Zuckerman, Ph.D. has over 15 years in bringing novel protein therapeutics, pharmaceuticals, and medical devices from R&D to clinical trials and on to licensure at the FDA, EMA, and other agencies with regulatory authority. She has secured the approval of several biologics and medical devices and her experience crosses a wide range of indications for use including: oncology, autoimmunity, and hemostasis.
Dr. Zuckerman will now bring her extensive drug development expertise to the global health problem of antibiotic resistance through her work at ID Genomics as the President and CEO, with the ultimate goal of realizing rapid, point-of care, diagnostic technologies to enable accurate prescribing habits for antibiotics across a wide range of microbial infections. She was previously the CEO of Xcede Technologies, Inc. and President of ProFibrix Inc. prior to joining ID Genomics. Her tenure also includes leadership and scientific positions at ZymoGenetics and Genentech Inc.

Elena Rechkina, Ph.D.

Director of Research and Development


Dr. Rechkina has an extensive experience and broad scientific background in molecular biology and has worked for over 7 years in industrial R&D of PCR diagnostics and production quality control.
For the last two years she has been with the Department of Microbiology, University of Washington, Seattle, and ID Genomics, where she became a leader in the qPCR-based clonotyping, whole genome sequencing and analysis, single nucleotide polymorphism detection and multi locus sequence typing.

Sandy Ryan, RAC

Director for Administrative and Quality Assurance/Regulatory Affairs

Ms. Ryan has over 12 years of experience in all phases of accounting, including but not limited to administration of government grants and yearly and quarterly financial implementation and oversight of quality and regulatory systems for a small IVD manufacturer; including development of Design History Files, Technical Files, Document control system, Device Master records, and lead for FDA Inspections and ISO 13485 Audits.

Veronika Tchesnokova, MD, Ph.D.

Scientific Director


Dr. Tchesnokova’s work includes the development and implementation of the study designs, reporting, overseeing the data integrity and quality control measures, statistical analysis of clinical and experimental data and providing counsel on all scientific engagements of the organization. Dr. Tchesnokova’s is also a research scientist in Microbiology at the University of Washington – School of Medicine. She has co-authored 59 peer-reviewed publications.